Home / Knowledge Centre /
Almac Voice

Navigating the complex world of radiopharmaceutical development with Almac

Developing a radiopharmaceutical agent for imaging and therapy is a complex and challenging endeavour. It starts with logistically challenging biodistribution studies using costly radionuclides. Once the candidate molecule is selected, securing a reliable manufacturer can also be a hard task. In a landscape where most production plants are optimised for large volumes and high throughput, finding the right partner for small-scale GMP peptide precursors tailored to the theranostics world can thus be daunting.

If you have faced hurdles in planning biodistribution studies due to the cost and time implications, and in securing a manufacturer with the necessary expertise, Almac is here to help you.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies